Nobivac Canine 1-Pv Vaccine

Supplied By: Merck (065300)


SKU
019466


Unit of
Measure 25 x 1 Dose


Pack
Type Box


Case
Qty 1

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024
{{purchaseHistoryItem}}


SKU 019466


Size 25 x 1 Dose

Case
Qty 1

Purchase History

Jan- 2025 {{productPurchaseHistory['019466'][0]}} Jun- 2024 {{productPurchaseHistory['019466'][0+7]}}
Dec- 2024 {{productPurchaseHistory['019466'][1]}} May- 2024 {{productPurchaseHistory['019466'][1+7]}}
Nov- 2024 {{productPurchaseHistory['019466'][2]}} Apr- 2024 {{productPurchaseHistory['019466'][2+7]}}
Oct- 2024 {{productPurchaseHistory['019466'][3]}} Mar- 2024 {{productPurchaseHistory['019466'][3+7]}}
Sep- 2024 {{productPurchaseHistory['019466'][4]}} Feb- 2024 {{productPurchaseHistory['019466'][4+7]}}
Aug- 2024 {{productPurchaseHistory['019466'][5]}} Jan- 2024 {{productPurchaseHistory['019466'][5+7]}}
Jul- 2024 {{productPurchaseHistory['019466'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Modified live virus containing a canine parvovirus type 2b strain for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine parvovirus.

Features & Benefits

  • Protects against all known CPV strains, including CPV-2c2,3
  • Contains CPV-2b, one of the most prevalent field strains of parvovirus
  • First to publish data showing protection against CPV-2c challenge2
  • Study showed no clinical signs of infection in vaccinated puppies after challenge with mixed CPV-2b and CPV-2c strains2
  • High antigenic mass (titer), low passage vaccine protects against all field strains currently seen
  • Multiple studies demonstrate the ability to override maternal antibodies